Why did Moleculin Biotech Inc (NASDAQ:MBRX) Have a Rough Week?

Moleculin Biotech Inc (NASDAQ:MBRX)

Moleculin Biotech Inc (NASDAQ:MBRX) stock fell through mild support at $2.50 to close the trading week at $2.39 on light volume. The biotechnology company spent early August trying to establish a price above $3.00 but failed to do so and slid down to establish a new low for August.

Moleculin Biotech Inc (NASDAQ:MBRX)
One month stock price chart for MBRX

Moleculin Biotech Inc. (NASDAQ:MBRX) is a pre-clinical pharmaceutical company with ties to The University of Texas System on behalf of M.D. Anderson Cancer Center. Moleculin Biotech Inc. (NASDAQ:MBRX) developed Annamycin for the treatment of acute myeloid leukemia (AML). AML is the most common type of leukemia in adults. Current treatment includes combining two chemotherapeutic drugs – a treatment regime that has not substantially changed since the 1970s. Annamyecin is a unique liposome formulated anthracycline designed to limit, or erase any cardiotoxicity during treatment. This approach is taken so as to avoid the multi-drug resistance mechanism that frequently defeat the effectiveness of current drugs.

Last Monday, August 14, 2017, Moleculin Biotech Inc (NASDAQ:MBRX) released their Q2 2017 financial results. The biotech company had a Q2 net loss of $2.3 million, which included non-cash income of $1.2 million related to some warrants expiring without being exercised. The market reacted to the news by selling MBRX shares off and they closed the day down over 6%.

Then on Wednesday, Moleculin Biotech Inc (NASDAQ:MBRX) announced it acquired the WP1122 active drug compound from the company’s sub-license partner in Poland. Moleculin Biotech plans to study the drug as a potential treatment for brain tumors.

Walter Klemp, CEO of Moleculin Biotech Inc (NASDAQ:MBRX), commented “Access to this product allows us to accelerate preclinical toxicology and analytical testing of WP1122, which enables preparation of an Investigational New Drug application so we can begin proof of concept clinical trials. Research at MD Anderson using live human brain tumors transplanted into mice has shown that WP1122 has the potential to outperform the current standard of care treatment for glioblastoma, one of the most pervasive forms of brain tumors.”

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $MBRX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Can AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) Stock Sustain Trend?

AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK)

AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) stock has doubled in value this week amongst massive increases in volume. On Monday AGTK stock opened at $0.0108, but by Thursday stock in the cannabis sector company closed at $0.0232. Volume for Monday came in at 1,497,876 but Thursday’s volume was a massive 41,775,908. Most experts believe that four days of gains, combined with exceptionally heavy trading volume, is a confirmation of higher AGTK stock price levels.

AGTK Stock Chart

AGTK Stock
One month stock price chart for AGTK

The legal cannabis industry has likely been, year to date, one of North America’s largest growth sectors in terms of the share prices of the companies involved. AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) operates within the medicinal marijuana space. Agritek itself does not directly grow, harvest, distribute, or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act, nor does it intend to do so in the future. Rather Agritek consults to companies that produce medicinal and recreational cannabis. Additionally, the company owns property in Colorado that may be used to grow cannabis. Through formalized partnerships with companies in California and Puerto Rico, Agritek has access manufacturing and processing capabilities. AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) also operates several Hemp and cannabis brands for distribution including MD Vapes, MicroDose Strips, “Hemp Pops” and “California Premiums.”

Yesterday, AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) announced that the company will be featured on the FOX Business News show “NEW TO THE STREET,” this Sunday.   In addition to Agritek Holdings, Inc. (OTCQB:AGTK), the show will also cover Genoil Inc. (OTCQB:GNOLF), Kimberly Parry Organics Corp. (OTCPINK:KPOC), Cannasaver, and DIB Funding Inc.-“DIBCOIN.”  The show’s broadcast is Sunday, August 20, 2017, at 2:00 PM Eastern/11:00 AM Pacific, airing nationwide on the FOX Business Network — reaching 95 million homes.

AGTK stock has a 52-week high of $0.08. National coverage of this stock may tempt speculators to allocate a small portion of their stock portfolio to the fast-rising company. With a market capitalization of just over $12 million, it may not take a lot to challenge its highs.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $AGTK and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Clean Diesel Technologies, Inc. (NASDAQ:CDTI) Has Great Week!

Clean Diesel Technologies, Inc. (NASDAQ:CDTI)

Clean Diesel Technologies, Inc. (NASDAQ:CDTI) shares are up over 30% for the week after the pollution treatment company posted Q2 2017 financials at the beginning of the week. However, the real move came on Wednesday and continued through Thursday morning. On Wednesday CDTI stock opened close to $1.60, then by late morning on Thursday the shares hit $2.32 for a gain of more than 40%. Since the trades over $2.30 the shares retreated to end the day at $2.03.

Clean Diesel Technologies, Inc. (NASDAQ:CDTI)
One month stock price chart for CDTI

Q2 2017 total revenue was $8.4 million for Clean Diesel Technologies, Inc. (NASDAQ:CDTI) which was no change from Q2 2016. Gross margin was 23% for Q2 2017, versus 20% for the same period from last year. Total operating expenses for Q2 2017 was $2.3 million, compared to $4.8 million for Q2 2016. The decrease reflects the 2016 implementation of Clean Diesel’s cost reduction initiatives as well as a reduction in the liability related to the exit of their Canadian manufacturing facility.  Clean Diesel Technologies, Inc. (NASDAQ:CDTI) achieved its goal to reduce ongoing operating expenses to $3.0 million in the second quarter and anticipates that operating expense will continue at this level or lower for the remainder of the year. Net loss was (-$385,000), or (-$0.02) per share, compared to a net loss of (-$222,000), or (-$0.06) per share for Q2 2016. Cash at June 30, 2017 was $1.6 million, compared to $7.8 million at December 31, 2016 including a $600,000 decrease in our line of credit since the first quarter.

Clean Diesel Technologies, Inc. (NASDAQ:CDTI) provided a forecast to the market. Based on their current business configuration and Q2 2017 results, Clean Diesel believes revenue will come in between $32.0 – $35.0 million with gross margins between 23% and 25%.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CDTI and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

MGT Capital Investments Inc. (OTCMKTS:MGTI) Making Move

MGT Capital Investments Inc. (OTCMKTS:MGTI)

MGT Capital Investments Inc. (OTCMKTS:MGTI) stock ended yesterday at $1.93 but has gained almost 15% to trade around the $2.20 level in mid-day action. The 30-day daily average volume for MGTI stock is listed at 596,787 but by 1:30PM EST over 2.2 million shares hand exchanged hands.

MGT Stock OTC Chart:

MGT Capital Investments Inc. (OTCMKTS:MGTI)
One month stock price chart for MGTI

Today, MGT Capital Investments Inc. (OTCMKTS:MGTI) announced the deployment of 650 new Bitmain S9 Bitcoin mining rigs. These units will be installed at a new facility located in central Washington state. MGT Capital Investments Inc. (OTCMKTS:MGTI) believes it will take two weeks to complete the installation and achieve full production capacity. With the Washington state facilities, MGT Capital Investments, Inc. (OTC: MGTI) has become one of the largest U.S. based Bitcoin miners and has an eye to continue its growth.

MGT Capital Investments Inc. (OTCMKTS:MGTI) recently passed the “one thousandth mined bitcoin” mark since the company began operations in September 2016. Robert Ladd, Chief Executive Officer of MGT commented, “We are committed to this sector and look forward to updating stockholders on our continuing growth.”

MGT Crypto-Capital Strategies President, Stephen Schaeffer, stated, “With the recent highs of $4,500 per bitcoin, the business of mining is as profitable as ever. I couldn’t be more excited about the timing of my new appointment, and I truly believe we will build MGT into a mining powerhouse in the U. S.”

The development of MGT Capital Investments Inc. (OTCMKTS:MGTI) portfolio of cyber security technologies is led by industry pioneer John McAfee. Mr. McAfee is also developing protection technologies for mobile and personal tech devices, as well as corporate networks. Sentinel is the company’s first product. It is an enterprise class network intrusion detector and is currently in beta testing. Its commercial release is believed to take place in the next 45 days. The Company also has entered into a joint venture with Nordic IT to develop and market a mobile phone with extensive privacy and anti-hacking features. The Privacy Phone has a tentative release date of February 2018.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $MGTI and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

American Cannabis Company Inc (OTCMKTS:AMMJ) Client Base Expands

American Cannabis Company Inc (OTCMKTS:AMMJ)

American Cannabis Company Inc (OTCMKTS:AMMJ) rallied 10.87% in Wednesday’s trading session as investors reacted to new contract deals that the company has signed in pursuit of revenue opportunities in the cannabis business. The company has inked deals in Arkansas and California as it continues to expand its footprint in the multibillion industry.

Shares of American Cannabis Company Inc (OTCMKTS:AMMJ) have been on an impressive run ever since they tanked to this year’s lows of $0.36 a share in June. The stock is currently trading at the higher end of its $0.67 – $0.82 a share range and faces resistance around $1 a share.

American Cannabis Company Inc (OTCMKTS:AMMJ)
One month stock price chart for AMMJ

American Cannabis Company Inc (OTCMKTS:AMMJ), along with its subsidiaries, provides consulting services and solutions to businesses in the legal cannabis business in the U.S and Canada. Some of the services that the company offers include commercial cannabis business planning, cannabis business license application, and cultivation build out oversight.

The business-to-business consulting solutions provider also owns a portfolio of branded products that include, The Satchel, The Cultivation Cube, and The High-Density Cultivation System.

Consulting Deals

The company is fresh from securing a new client in the fast growing California cannabis industry. The client is in the process of acquiring licenses needed to dispense medical cannabis in the state. American Cannabis Company Inc (OTCMKTS:AMMJ) has been tasked with the responsibility of coming up with complete operational planning activities for a retail location.

The California client has also asked American Cannabis to provide facility staffing solutions, operational workflow procedures and remote operational monitoring systems, pending the approval of the licenses.

“This state, while deeper than most states in its cannabis industry history and tenure, continues to present vast amounts of opportunity within the marketplace. As a company, ACC is actively seeking to align itself with strong clients who have an understanding of what it takes to achieve success,” said CEO, Terry Buffalo.

In addition to the new client in California, the consulting solutions provider has secured a third client in the state of Arkansas. American Cannabis Company Inc (OTCMKTS:AMMJ) will furnish the new client with a robust financial pro-forma modeling while also helping him develop a custom business plan and conceptual design work.

American Cannabis Company Inc. (OTCMKTS:AMMJ) plans to leverage the new deals to secure additional revenue streams through long-term consulting agreements.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $AMMJ and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Is Westport Fuel Systems Inc (USA) (NASDAQ:WPRT) Topping Out?

Westport Fuel Systems Inc (USA) (NASDAQ:WPRT)

The Q2 2017 financial release by Westport Fuel Systems Inc (USA) (NASDAQ:WPRT) supported a two-day run that moderated in the last half of today’s trading day. On Monday WPRT stock ended trading around $1.90. On Tuesday the stock gapped higher to open and ended at $2.20. WPRT shares gapped up to open again Wednesday morning and quickly hit $2.39 when sellers stepped in and proceeded to take the stock down throughout the day. WPRT stock closed at $2.23. Volume was about 3.5 times the daily average.

Westport Fuel Stock Chart:

Westport Fuel Systems Inc (USA) (NASDAQ:WPRT)
One month stock price chart for WPRT

Westport Fuel Systems Inc (USA) (NASDAQ:WPRT) is a transportation green technology company. Westport develops, manufactures, and markets clean-burning fuel systems and components. The company wants to change the way the world moves in a manner that creates value for their employees, customers, investors, and benefits the environment. Westport operates globally in more than 70 countries.

Westport Fuel Systems Inc (USA) (NASDAQ:WPRT) reported a Q2 2017 adjusted net loss of (-$0.12) per share from continuing operations. That loss was less than the street’s expected (-$0.15) loss and is likely what sent WPRT shares higher. Adjusted net income was reported at $0.04 per share. Total net loss from continuing operations amounted to $13.3 million. The reported net income for second-quarter 2016 was $3.4 million. Westport Fuel Systems posted Q2 consolidated revenues of $62.1 million, up 66.9% for the same period of the previous year and $7.1 million more than the consensus estimate. Growth was primarily driven by the addition of Fuel Systems’ revenues. Q2 consolidated gross margin increased to $15.8 million (25.4% of sales) from $8.2 million (21.9% of sales) recorded in Q2 of 2016. The improvement in gross margin came on the back of the Fuel Systems’ merger. Consolidated adjusted EBITDA amounted to a negative (-$5.3) million, compared with a negative (-$11.5) million in Q2 2016.

Westport Fuel Systems Inc (USA) (NASDAQ:WPRT) is up over 97% YTD, and up over 33% for the year.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $WPRT and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Inpixon (NASDAQ:INPX) Enjoys Uncharacteristic Pop!

Inpixon (NASDAQ:INPX)

Inpixon (NASDAQ:INPX) stock has been battered for the last year but today shares are up over 33% after news that it entered into a receivables and purchase order funding agreement with Payplant, LLC and replaced the existing $1.4 million loan to Gemcap. INPX stock has a 30-day, daily average trading volume of 600,000 but before close of trading today over 3.3 million shares have exchanged hands. Last week, the company announced that their subsidiary, Inpixon Federal, received two delivery orders from the Bureau of Census, based on Inpixon Federal’s GSA IT 70 Schedule, for a one year software Enterprise License Agreement (ELA) and 24×7 maintenance. The value of the orders was posted at over $1.4M.

Inpixon stock chart:

Inpixon (NASDAQ:INPX)
one month stock price chart for INPX

Inpixon (NASDAQ:INPX) is a leader in indoor positioning and data analytics. Inpixon sensors are designed to anonymously locate cellular, Wi-Fi, and Bluetooth devices. Paired with a high performance, data analytics platform this technology delivers visibility, security, and business intelligence in any facility. Inpixon’s products, infrastructure solutions, and professional services group help customers take advantage of mobile, big data, analytics, and the Internet of Things (IoT) to uncover data that can help them better perform their task be it governmental or commercial in nature.

Performance has been poor for Inpixon (NASDAQ:INPX). YTD shareholders have seen a return of (-92.62%), and the shares are down over 95% for the year. While INPX shares are up over their 52-week low of $0.19, they are fall below their 52-week high of $11.08. The lone investment company that follows INPX rates the shares as a “Hold”. That rating is considered charitable by some as the company has posted an expanding loss per share every year since 2012 when it posted a loss of (-$0.74) per share. In 2016 the loss had expanded to a loss of (-$15.17) per share. Sales also dipped in 2016 when the company posted a figure of $53.2 million or $13.8 million below posted 2015 sales.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $INPX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Will Helios and Matheson Analytics Inc (NASDAQ:HMNY) Grab Movie Magic?

Helios and Matheson Analytics Inc (NASDAQ:HMNY)

Helios and Matheson Analytics Inc (NASDAQ:HMNY) gapped up to open on Tuesday morning, reached above $3.80, then retreated throughout the day and into today’s session to trade in a tight range around $2.60. Volume has been heavy – almost double the stock’s daily average.

Helios and Matheson Analytics Inc (NASDAQ:HMNY)
One month stock price chart for HMNY

The market is responding to the company’s announcement that it has bought a 51% majority stake in MoviePass, a subscription-based service for movie theaters led by former Netflix executive and co-founder Mitch Lowe. Helios and Matheson Analytics Inc (NASDAQ:HMNY) paid $27 million for the equity.

The two New York city-based companies simultaneously launched a monthly subscription service with a price-point at $9.95. The subscription entitles the subscriber entry into one movie every 24 hours at any of the participating 3,700 U.S. movie theaters. Prior to the deal, subscription plans from MoviePass ranged anywhere from $14 to $50 per month.

Lowe served as the vice president of business development and strategic alliances for Netflix, from 1998 to 2003. He also held executive positions at RedBox Automated Retail LLC from 2005 to 2011, including, for four years, as the company’s CEO. In June of 2016, Lowe was installed as CEO at MoviePass.

The subscription plan is one facet of the company’s strategy to increase movie attendance which has been trending downwards along with the popularity of shopping malls. Enticement include reserved seating, pre-ordering drinks and food, and free large-screen viewing of popular TV shows throughout the day. The new approach was designed to broaden the demographics of movie attendees. Currently over 70% of movie theater viewers are millennials. By offering a more upscale service, Helios and Matheson Analytics Inc (NASDAQ:HMNY) hope to attract a more mature consumer.

One year ago Helios and Matheson Analytics Inc (NASDAQ:HMNY) stock was trading above $13. For the past few months HMNY shares have been trading between $2 and $3. YTD the stock is down only 10% but for the year HMNY shares are down over 67%. Interested investors or traders should note that 15% of the stock’s float is held by short-sellers.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $HMNY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Atacama Resources International Inc (OTCMKTS:ACRL) Rallies

Atacama Resources International Inc (OTCMKTS:ACRL)

Atacama Resources International Inc (OTCMKTS:ACRL) rallied 30.43% in Tuesday’s trading session as investors reacted to the outcome of the company’s annual general meeting and prepayment of a convertible promissory note. The meeting held on August 11, 2017, saw the company detail its revenue projections for the year as well as provide corporate highlights.

Atacama Resources International Inc (OTCMKTS:ACRL)
One month stock price chart for ACRL

Tuesday’s rally did little to reverse a strong downward trend that has pushed the stock to this year’s low. The stock has underperformed the overall industry after dropping from March highs of $0.45 a share.

Atacama Resources International Inc. (OTCMKTS:ACRL) bills itself as a consulting company, focused on providing services to companies and individuals participating in the mining industry. The company also manages actual mining operations. Its 40 mining claims include a 1,680-acre mine in the Kirkland area of Ontario. In addition, the company owns and sells smartphone applications.

 Smartphone Apps Push

During the annual general meeting, Atacama Resources International Inc (OTCMKTS:ACRL) detailed a new smartphone app slated for release early next year. Dubbed SeniorGuard, the new app should strengthen the company’s suite of safety-driven mobile applications front that is currently made up of the Good2Drive app.

Good2Drive mobile app is designed to test driver’s cognitive alertness before they get behind the wheel in cars. The app monitors impairment to driver’s judgment which may be caused by alcohol, medical condition prescription, and illicit drugs. The mobile app is currently available in iTunes and Google Play stores.

Stock Promotion Concerns

Due to the high volume of shares traded, Atacama Resources International Inc. (OTCMKTS:ACRL) says it recently carried out an internal investigation to ensure that all the company’s officials and directors comply with SEC and FINRA rules. The audit came after the company was informed about possible illegal stock promotion activities.

Atacama Resources International Inc (OTCMKTS:ACRL) has since refuted claims of stock promotion activities by reiterating it had no involvement or knowledge of any material posted with regards to the same.

In addition, the company says it prepaid in cash a convertible promissory note late last month, which will now be converted into shares this month.

“By recent board action, the company policy will be, if at all possible, to prepay convertible notes prior to any conversion to ACRL shares. ACRL was not required to convert several million shares as the result of the prepayment,” Atacama Resources International Inc (OTCMKTS:ACRL) in a statement.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ACRL and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Cumulus Media Inc (NASDAQ:CMLS) Shares Experience Upside Volatility

Cumulus Media Inc (NASDAQ:CMLS)

Cumulus Media Inc (NASDAQ:CMLS) stock ended the trading day 7.0% higher after the company announced yesterday a profit $5.7 million or $0.19 per share. The normally thinly-traded stock traded at more than four times its average daily volume.

Cumulus Media Stock Chart:

About Cumulus Media Inc.

Cumulus Media Inc (NASDAQ:CMLS), headquartered in Atlanta, GA, owns and operates radio stations in the United States. The company operates under two brands, Radio Station Group and Westwood One. Revenues are generated through the sale of commercial advertising time to local, regional, and national advertisers as well as network advertising. Cumulus creates and broadcasts content through approximately 445 owned-and-operated stations in 90 United States media markets; and approximately 8,200 broadcast radio affiliates and various digital channels.

Cumulus Media Inc. Released Financials

Cumulus Media Inc (NASDAQ:CMLS) reported net revenue of $290.5 million, up 1.2% from Q2 2016. The company reported net income of $5.7 million and Adjusted EBITDA of $67.4 million – up 6.7% from the same period for 2016. For the six months ended June 30, 2017, Cumulus Media posted net revenue of 554.6 million, down 0.2% from the six months ended June 30, 2016. The company had a net loss of $1.7 million and Adjusted EBITDA of $106.1 million which was up 1.0% from the six months ended June 30, 2016.

Mary Berner, President and Chief Executive Officer of Cumulus Media Inc (NASDAQ:CMLS) said, “Our second quarter results provide further evidence of the success of our turnaround strategies as we posted a year-over-year increase in Adjusted EBITDA for the first time in over three years despite what continues to be a tough market environment.”

In early 2014, CMLS shares were trading above $60. However, they have been on a long consistent slide since then. CMLS stock is down over 57% YTD and down almost 85% for the year. Interestingly, as earnings have suffered, sales have been less volatile. In 2014 the company posted a sales figure of $1.26 million, and just two years later the posted sales figure came in at $1.14 million.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CLMS and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.